Heghine Khachatryan: Dementia at the Intersection of Hematology and Hemostasis
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“Dementia: At the Intersection of Hematology and Hemostasis
Emerging evidence increasingly supports that cognitive impairment is often multifactorial, with significant contributions not only from metabolic abnormalities, but also from hemostatic dysregulation.
In the diagnostic approach to dementia, the concept of reversible causes must be expanded to include thrombotic–hemostatic mechanisms and microcirculatory dysfunction.
Why Hemostasis Matters in Cognitive Decline
Cerebral function is highly sensitive to:
- Microthrombosis
- Endothelial dysfunction
- Chronic hypoperfusion
- Inflammation-driven vascular injury
These processes contribute to vascular cognitive impairment, often under-recognized within the broader dementia spectrum.
Hemostatic Red Flags
- Unexplained thrombosis
- Recurrent stroke / TIA
- Silent cerebral infarcts
- Elevated D-dimer / fibrinogen
- Antiphospholipid antibodies
- Cytopenias or macrocytosis
Key Hemostatic Contributors
- Antiphospholipid syndrome (APS)
- Hypercoagulable states
- Hyperviscosity syndromes (WM, myeloma)
- Malignancy-associated microthrombosis
- Endothelial dysfunction
What to Include in Workup
- Coagulation profile
- D-dimer
- APS panel
- Thrombophilia testing (selected cases)
- Serum viscosity / SPEP
Take-Home Message
Dementia is not always purely neurodegenerative.
In selected cases, it may reflect microthrombotic and hemostatic pathology – potentially modifiable if identified early.
Call to Action
Hematologists should be actively involved in the multidisciplinary evaluation of cognitive disorders.
Because sometimes, the origin of cognitive decline lies in the hemostatic system. ”
Stay updated with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow